Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects

Clinical trial NCT03562416 · TERMINATED

Trial details

NCT number: NCT03562416
Sponsor: Temple University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis Lung Transplant; Complications

Start date: 2019-07-05
Primary completion: 2021-12-21
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.